aap Implantate AG (AAQ):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:aap Implantate AG (AAQ) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6453
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
aap Implantate AG (aap Implantate) is a medical device company, which develops, manufactures and markets trauma products and biomaterials for orthopedic treatment. Its products include locked plating systems for anatomical reduction, cannulated screws, standard plates and screws for osteosynthesis, and orthopedic implants, besides trauma complementary biomaterials such as bone graft substitutes, and bone replacement materials. The pipeline of aap Implantate includes antibacterial silver coating technology and magnesium based implants for use in surgery. The company offers its products to hospitals, purchasing syndicates and hospital groups. Its products are used in the specialty areas of trauma and spine repair. The company markets its products directly and through a network of distributors worldwide. aap Implantate is headquartered in Berlin, Germany.

aap Implantate AG (AAQ) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
aap Implantate AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
aap Implantate AG, Medical Equipment Deals By Type, 2012 to YTD 2018 7
aap Implantate AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
aap Implantate AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
aap Implantate AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
aap Implantate AG, Medical Equipment, Deal Details 11
Private Equity 11
Keensight Capital Acquires aap Biomaterials from aap Implantate for USD41 Million 11
aap Implantate Sells European Medical Contract Manufacturing for USD25.7 Million 13
aap Implantate Sells 67% Stake in aap Joints to Private Equity Firm 14
Partnerships 15
aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 15
Integra LifeSciences Holdings Enters into Agreement with aap Implantate 16
aap Implantate Enters into Agreement with US Based Healthcare Service Provider 17
aap Implantate Forms Joint Venture With Dongguan Eontec To Develop Medical Implants 18
Integra LifeSciences Enters Into Distribution Agreement With aap Implantate For Stainless Headed Compression Screw System 19
aap Implantate Enters Into Licensing Agreement With Bioscompass For Adcon Gel 20
Acquisition 21
aap Implantate Sells Remaining 33% Stake in aap Joints 21
Botiss Medical Acquires Remaining 50% Joint Venture Interest in AAP BM Productions from aap Implantate 22
aap Implantate AG – Key Competitors 23
aap Implantate AG – Key Employees 24
aap Implantate AG – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Aug 14, 2018: aap Implantate: Double-digit Q2/2018 sales growth; sales and EBITDA at upper end of guidance 26
May 14, 2018: aap Implantate: Sound start to 2018 with sales and EBITDA at the upper end of the guidance 28
Aug 14, 2017: aap: Q2 sales and EBITDA in line with guidance; 14% sales growth in trauma in H1/2017aap: Q2 sales and EBITDA in line with guidance; 14% sales growth in trauma in H1/2017Berlin, 14 August 2017 29
Aug 14, 2017: aap Implantate: Q2 sales and EBITDA in line with guidance; 14% sales growth in trauma in H1/2017 31
May 15, 2017: aap Implantate: Successful start in 2017 with sales and EBITDA increase – 30% sales growth in trauma in Q1/2017 33
Apr 24, 2017: aap Implantate: 30% sales growth in trauma in the first quarter of 2017 35
Mar 31, 2017: aap: Annual financial statements for 2016: aap with fundamental progress in strategy implementation – Transformation to a pure player in trauma completed 36
Feb 28, 2017: aap: Sales in Q4/2016 at EUR 2.4 million and in FY/2016 at EUR 11.2 million; sales growth in established markets and EBITDA improvement planned for FY/2017 38
Corporate Communications 41
Jun 15, 2017: aap: Supervisory Board extends both Management Board members’ contracts prematurely until the end of 2020 41
Legal and Regulatory 42
Oct 01, 2017: OSARTIS – new logo of aap Biomaterials – new corporate design 42
Other Significant Developments 43
Feb 15, 2018: aap Implantate: 20% Trauma Sales Growth in 2017 43
Nov 14, 2017: aap Implantate: Double-digit trauma sales growth in Q3 and 9M/2017 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
aap Implantate AG, Medical Equipment, Key Facts, 2017 2
aap Implantate AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
aap Implantate AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
aap Implantate AG, Medical Equipment Deals By Type, 2012 to YTD 2018 7
aap Implantate AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
aap Implantate AG, Deals By Market, 2012 to YTD 2018 9
aap Implantate AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Keensight Capital Acquires aap Biomaterials from aap Implantate for USD41 Million 11
aap Implantate Sells European Medical Contract Manufacturing for USD25.7 Million 13
aap Implantate Sells 67% Stake in aap Joints to Private Equity Firm 14
aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 15
Integra LifeSciences Holdings Enters into Agreement with aap Implantate 16
aap Implantate Enters into Agreement with US Based Healthcare Service Provider 17
aap Implantate Forms Joint Venture With Dongguan Eontec To Develop Medical Implants 18
Integra LifeSciences Enters Into Distribution Agreement With aap Implantate For Stainless Headed Compression Screw System 19
aap Implantate Enters Into Licensing Agreement With Bioscompass For Adcon Gel 20
aap Implantate Sells Remaining 33% Stake in aap Joints 21
Botiss Medical Acquires Remaining 50% Joint Venture Interest in AAP BM Productions from aap Implantate 22
aap Implantate AG, Key Competitors 23
aap Implantate AG, Key Employees 24
aap Implantate AG, Subsidiaries 25

List of Figures
aap Implantate AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
aap Implantate AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
aap Implantate AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
aap Implantate AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
aap Implantate AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
aap Implantate AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
aap Implantate AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
aap Implantate AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[aap Implantate AG (AAQ):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Accenture Plc (ACN):企業の財務・戦略的SWOT分析
    Accenture Plc (ACN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Fresenius Kabi AG:企業の戦略的SWOT分析
    Fresenius Kabi AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Fluxion Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary Fluxion Biosciences Inc (Fluxion) is a provider of analytical and live cell analysis tools. The company’s products include IsoFlux system and CTC kits, BioFlux System, IonFlux System, Cytation CTC imager and enumeration kits, and sequencing kits. It provides analytical services for a range o …
  • Select Medical Holdings Corporation:企業の戦略・SWOT・財務分析
    Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Cooper-Standard Holdings Inc.:企業の戦略・SWOT・財務情報
    Cooper-Standard Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Cooper-Standard Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Hinduja Global Solutions Ltd (HGS):企業の財務・戦略的SWOT分析
    Hinduja Global Solutions Ltd (HGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • MEAG Munich Ergo AssetManagement GmbH:電力:M&Aディール及び事業提携情報
    Summary MEAG Munich Ergo AssetManagement GmbH (MEAG Munich), a subsidiary of Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft (Munich Re) is an asset management company that manages assets of Munich Re and ERGO Insurance Group and its affiliates. The company offers services such as asset …
  • China Resources Power Holdings Co Ltd:発電所・企業SWOT分析
    China Resources Power Holdings Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Career Education Corporation (CECO):企業の財務・戦略的SWOT分析
    Career Education Corporation (CECO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Nuvaira Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nuvaira Inc (Nuvaira), formerly Holaira Inc is an independent medical device company that strives to develop minimally invasive products for the treatment of obstructive lung diseases. It provides Lung Denervation System, a catheter-based system intended for asthma and chronic obstructive pu …
  • Pernod Ricard SA:企業の戦略・SWOT・財務情報
    Pernod Ricard SA - Strategy, SWOT and Corporate Finance Report Summary Pernod Ricard SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Regeneron Pharmaceuticals Inc (REGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Regeneron Pharmaceuticals Inc (Regeneron) is a biopharmaceutical company, which discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The company’s six US FDA-approved medicines and product candidates in development help patients wit …
  • The Bank Of East Asia, Limited:企業の戦略・SWOT・財務分析
    The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Prothena Corp Plc (PRTA):企業の財務・戦略的SWOT分析
    Summary Prothena Corp Plc (Prothena) discovers and develops therapies for the treatment of neurological disorders. It is evaluating Prasinezumab (PRX002/RG7935), a monoclonal antibody targeting alpha-synuclein protein, against Parkinson’s disease and other related synucleinopathies; and PRX004, an i …
  • Ajinomoto Co Inc (2802):製薬・医療:M&Aディール及び事業提携情報
    Summary Ajinomoto Co Inc (Ajinomoto) is a food products company that focuses on foods, bioscience fine chemicals and pharmaceuticals and health. It carries out research and development and production of seasonings, and provides Knorr cup soup products, processed foods, edible oils, sweeteners, bever …
  • Telkom SA SOC Limited:戦略・SWOT・企業財務分析
    Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report Summary Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ziehm Imaging GmbH-医療機器分野:企業M&A・提携分析
    Summary Ziehm Imaging GmbH (Ziehm Imaging) is a medical device company that specializes in the development, production and global marketing of mobile X-ray based imaging solutions. The company's product portfolio includes ziehm vision RFD 3D, ziehm vision RFD hybrid edition, ziehm vision RFD, ziehm …
  • China High Speed Transmission Equipment Group Co Ltd (658):企業の財務・戦略的SWOT分析
    China High Speed Transmission Equipment Group Co Ltd (658) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the compa …
  • ADDvise Group AB (ADDV A):企業の財務・戦略的SWOT分析
    Summary ADDvise Group AB (ADDvise), formerly ADDvise Lab Solutions AB, is a medical device company that manufactures and markets healthcare and laboratory equipment. The company offers laboratory products such as laboratory equipments, furnishings, safety ventilation, centrifuges, climate chambers, …
  • BioMarin Pharmaceutical Inc (BMRN):企業の財務・戦略的SWOT分析
    BioMarin Pharmaceutical Inc (BMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆